Edwards Lifesciences
1,089 hedge funds and large institutions have $40.3B invested in Edwards Lifesciences in 2019 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 350 increasing their positions, 358 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,089
Holders Change
+126
Holders Change %
+13.08%
% of All Funds
21.5%
Holding in Top 10
29
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-3.33%
% of All Funds
0.57%
New
195
Increased
350
Reduced
358
Closed
54
Calls
$259M
Puts
$261M
Net Calls
-$2.37M
Net Calls Change
-$93.5M
Top Buyers
| 1 |
BlackRock
New York
|
$4.25B |
| 2 |
Capital International Investors
Los Angeles,
California
|
$1.04B |
| 3 |
Goldman Sachs
New York
|
$421M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
$127M |
| 5 |
Two Sigma Investments
New York
|
$130M |
Top Sellers
| 1 |
Sands Capital Management
Arlington,
Virginia
|
$1.42B |
| 2 |
Jennison Associates
New York
|
$1.14B |
| 3 |
Citadel Advisors
Miami,
Florida
|
$20.6M |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
$674M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
$815M |